Camden Capital, LLC Eli Lilly & CO Transaction History

Camden Capital, LLC

$916 Million
Q1 2025

A detailed history of Camden Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Camden Capital, LLC holds 5,474 shares of LLY stock, worth $4.01 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

5,474

Previous 5,676 3.56%

Holding current value

$4.01 Million

Previous $4.38 Million 3.2%

% of portfolio

0.49%

Previous 0.49%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$725.72 - $929.72 $146,595 - $187,803	-202 Reduced 3.56%	5,474 $4.52 Million
Q4 2024 Jan 29, 2025	BUY	$727.2 - $932.06 $2.13 Million - $2.74 Million	2,935 Added 107.08%	5,676 $4.38 Million
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $494,941 - $615,372	641 Added 30.52%	2,741 $2.43 Million
Q2 2024 Aug 06, 2024	SELL	$724.87 - $909.04 $1.32 Million - $1.65 Million	-1,819 Reduced 46.41%	2,100 $1.9 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $3.56 Million - $4.76 Million	-6,014 Reduced 60.55%	3,919 $3.05 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $3.97 Million - $4.68 Million	7,564 Added 319.29%	9,933 $5.79 Million
Q3 2023 Nov 03, 2023	BUY	$434.7 - $599.3 $52,164 - $71,916	120 Added 5.34%	2,369 $1.27 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $44,894 - $60,029	-128 Reduced 5.38%	2,249 $1.05 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $50,322 - $59,100	162 Added 7.31%	2,377 $816,000
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $362,386 - $422,253	-1,127 Reduced 33.72%	2,215 $810,000
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $424,855 - $484,167	1,433 Added 75.07%	3,342 $1.08 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $59,369 - $69,708	213 Added 12.56%	1,909 $619,000
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $61,488 - $76,414	262 Added 18.27%	1,696 $486,000
Q4 2021 Feb 28, 2022	SELL	$224.85 - $279.04 $311,417 - $386,470	-1,385 Reduced 49.13%	1,434 $396,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $59,360 - $73,666	264 Added 10.33%	2,819 $779,000
Q3 2021 Nov 03, 2021	BUY	$221.6 - $272.71 $91,299 - $112,356	412 Added 19.23%	2,555 $590,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $51,998 - $67,259	288 Added 15.53%	2,143 $492,000
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $29,413 - $38,076	-179 Reduced 8.8%	1,855 $347,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $265,355 - $351,129	2,034 New	2,034 $343,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $245,555 - $295,524	-1,800 Closed	0 $0
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $38,215 - $47,299	-321 Reduced 15.13%	1,800 $249,000
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $226,777 - $280,884	2,121 New	2,121 $279,000

Others Institutions Holding LLY

# of Institutions

4,384

Shares Held

822M

Call Options Held

9.53M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $697B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Eli Lilly & CO Transaction History